Gauldie J - Search Results

1

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. Moeller A, et al. Among authors: gauldie j. Int J Biochem Cell Biol. 2008;40(3):362-82. doi: 10.1016/j.biocel.2007.08.011. Epub 2007 Aug 30. Int J Biochem Cell Biol. 2008. PMID: 17936056 Free PMC article. Review.

2

A new direction in the pathogenesis of idiopathic pulmonary fibrosis?

Gauldie J, Kolb M, Sime PJ. Gauldie J, et al. Respir Res. 2002;3(1):1. doi: 10.1186/rr158. Epub 2001 Sep 26. Respir Res. 2002. PMID: 11806836 Free PMC article. Review.

3

Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs.

Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, Kolb M. Bonniaud P, et al. Among authors: gauldie j. Am J Respir Cell Mol Biol. 2004 Nov;31(5):510-6. doi: 10.1165/rcmb.2004-0158OC. Epub 2004 Jul 15. Am J Respir Cell Mol Biol. 2004. PMID: 15256388

4

Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls.

Ask K, Martin GE, Kolb M, Gauldie J. Ask K, et al. Among authors: gauldie j. Proc Am Thorac Soc. 2006 Jun;3(4):389-93. doi: 10.1513/pats.200602-021TK. Proc Am Thorac Soc. 2006. PMID: 16738206 Review.

5

Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3.

Ask K, Bonniaud P, Maass K, Eickelberg O, Margetts PJ, Warburton D, Groffen J, Gauldie J, Kolb M. Ask K, et al. Among authors: gauldie j. Int J Biochem Cell Biol. 2008;40(3):484-95. doi: 10.1016/j.biocel.2007.08.016. Epub 2007 Sep 6. Int J Biochem Cell Biol. 2008. PMID: 17931953 Free PMC article.

6

Comparison between conventional and "clinical" assessment of experimental lung fibrosis.

Ask K, Labiris R, Farkas L, Moeller A, Froese A, Farncombe T, McClelland GB, Inman M, Gauldie J, Kolb MR. Ask K, et al. Among authors: gauldie j. J Transl Med. 2008 Apr 10;6:16. doi: 10.1186/1479-5876-6-16. J Transl Med. 2008. PMID: 18402687 Free PMC article.

7

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.

Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O'Byrne PM, Strieter RM, Kolb M. Moeller A, et al. Among authors: gauldie j. Am J Respir Crit Care Med. 2009 Apr 1;179(7):588-94. doi: 10.1164/rccm.200810-1534OC. Epub 2009 Jan 16. Am J Respir Crit Care Med. 2009. PMID: 19151190

8

VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Farkas L, Farkas D, Ask K, Möller A, Gauldie J, Margetts P, Inman M, Kolb M. Farkas L, et al. Among authors: gauldie j. J Clin Invest. 2009 May;119(5):1298-311. doi: 10.1172/JCI36136. Epub 2009 Apr 20. J Clin Invest. 2009. PMID: 19381013 Free PMC article.

9

Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.

Farkas L, Gauldie J, Voelkel NF, Kolb M. Farkas L, et al. Among authors: gauldie j. Am J Respir Cell Mol Biol. 2011 Jul;45(1):1-15. doi: 10.1165/rcmb.2010-0365TR. Epub 2010 Nov 5. Am J Respir Cell Mol Biol. 2011. PMID: 21057104 Review.

10

New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.

Baroke E, Gauldie J, Kolb M. Baroke E, et al. Among authors: gauldie j. Expert Rev Respir Med. 2013 Oct;7(5):465-78. doi: 10.1586/17476348.2013.838015. Expert Rev Respir Med. 2013. PMID: 24138691 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page